These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2289831)

  • 21. Intradialytic cytokine gene expression.
    Roccatello D; Menegatti E; Alfieri V; Rossi D; DeLuca A; Pignone E; Mengozzi G; Cesano G; Formica M; Martina G; Sena LM; Piccoli G
    Blood Purif; 1998; 16(1):30-6. PubMed ID: 9513760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Atti M
    ASAIO J; 1992; 38(1):52-4. PubMed ID: 1313318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis].
    Peona C; Fortina A; Colombo P; Filiberti O; Cagna G; Costantini L; Porcu M
    Minerva Urol Nefrol; 1991; 43(3):175-9. PubMed ID: 1726274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodialysis membranes modulate chronically the production of TNF alpha, IL1 beta and IL6.
    Mege JL; Olmer M; Purgus R; Bertocchio P; Farnarier C; Kaplanski S; Capo C; Bongrand P
    Nephrol Dial Transplant; 1991; 6(11):868-75. PubMed ID: 1775252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of dialyzer material and dialysate composition on hypoxemia during hemodialysis].
    Igarashi H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 May; 24(5):531-40. PubMed ID: 3761768
    [No Abstract]   [Full Text] [Related]  

  • 26. Elevated levels of tumor necrosis factor alpha in postdialysis fatigue.
    Dreisbach AW; Hendrickson T; Beezhold D; Riesenberg LA; Sklar AH
    Int J Artif Organs; 1998 Feb; 21(2):83-6. PubMed ID: 9569129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
    Sulková S; Votruba T; Lapcík O; Válek A
    Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
    Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
    ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The study of IL-1 beta, TNF-alpha, IL-6 gene expression and plasma levels on hemodialysis before and after dialyzer reuse.
    Qian J; Yu Z; Dai H; Huang P; Zhang Q; Cheng F; Chen S
    Chin Med J (Engl); 1997 Jul; 110(7):508-11. PubMed ID: 9594206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
    Hosokawa S; Yoshida O
    Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta2-microglobulin and IgE release during hemodialysis with cuprophan membrane.
    Stefanović V; Savić V; Rajić M; Mitić-Zlatković M
    Int J Artif Organs; 1997 Dec; 20(12):713-4. PubMed ID: 9506789
    [No Abstract]   [Full Text] [Related]  

  • 33. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term influence of dialysis treatment on beta 2-microglobulin, interleukin-2 R and tumour necrosis factor.
    Bandiani G; Camaiora E; Farina D; Nicolini MA; Perotta U; Tagliazucchi A
    Nephrol Dial Transplant; 1991; 6 Suppl 2():61-3. PubMed ID: 1866071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH; Lemke HD; Wanner C
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression.
    Zaoui PM; Stone WJ; Hakim RM
    Kidney Int; 1990 Nov; 38(5):962-8. PubMed ID: 2266681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.